A recently published study on novel malaria vaccines features Attana’s technology
A recent study published in Nature Communications enables a novel design of second-generation placental malaria vaccines. Attana’s technology played a vital role in the research and the study’s discoveries.Plasmodium falciparum is the most lethal human malaria parasite causing placental malaria. It is well-known that pregnant women have a higher risk of being infected and placental malaria is estimated to result in 900,000 low birth weight deliveries each year in Africa alone. However, after exposure to malaria during pregnancy, women develop antibodies against VAR2CSA, a plasmodium